Molecular profiling reveals novel therapeutic targets and clonal evolution in ovarian clear cell carcinoma
Abstract Background Ovarian clear cell carcinoma (OCCC) has a disproportionately high incidence among women in East Asia. Patients diagnosed with OCCC tend to experience worse clinical outcomes than those with high-grade serous carcinoma (HGSC) at advanced stages. The unfavorable prognosis of OCCC c...
Principais autores: | , , , , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
BMC
2024-11-01
|
coleção: | BMC Cancer |
Assuntos: | |
Acesso em linha: | https://doi.org/10.1186/s12885-024-13125-5 |